A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. [electronic resource]
Producer: 20050414Description: 423-8 p. digitalISSN:- 0022-5223
- Adolescent
- Adult
- Aged
- Biomarkers -- blood
- Cardiopulmonary Bypass
- Complement Inactivator Proteins -- antagonists & inhibitors
- Complement System Proteins -- drug effects
- Double-Blind Method
- Female
- Graft Rejection -- etiology
- Humans
- Length of Stay
- Lung Diseases -- mortality
- Lung Transplantation
- Male
- Middle Aged
- North America
- Oxygen Consumption -- drug effects
- Postoperative Complications -- etiology
- Receptors, Complement -- antagonists & inhibitors
- Reperfusion Injury -- etiology
- Respiration, Artificial
- Surgical Wound Infection -- etiology
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.